Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT01165996 · COMPLETED

Trial details

NCT number: NCT01165996
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ringed Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Thrombocytopenia

Start date: 2010-07-01
Primary completion: 2011-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.